By Michele Maatouk
Date: Monday 04 Mar 2024
(Sharecast News) - Renalytix surged on Monday after saying it had received an unsolicited takeover approach from "a large and well-capitalised publicly listed strategic diagnostics company".
By Josh White
Date: Friday 09 Feb 2024
(Sharecast News) - Renalytix shares were rocketing on Friday morning, after it announced that the Centers for Medicare and Medicaid Services (CMS) in the US had published a draft local coverage determination (LCD) for its 'KidneyIntelX' and 'kidneyintelX.dkd' testing products, outlining the coverage and pricing for the tests.
By Josh White
Date: Friday 06 Oct 2023
(Sharecast News) - Diagnostic artificial intelligence (AI) specialist Renalytix announced an enhancement to its intellectual property portfolio for its KidneyIntelX.dkd test on Friday.
Currency | UK Pounds |
Share Price | 30.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 145.00 |
52 Week Low | 10.25 |
Volume | 1,275 |
Shares Issued | 126.22m |
Market Cap | £37.87m |
RiskGrade | 348 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
11:39 | 380 @ 29.69p |
11:15 | 10 @ 29.70p |
08:03 | 884 @ 29.20p |
08:00 | 1 @ 29.79p |
You are here: research